Protara Therapeutics (TARA) Earnings Date, Estimates & Call Transcripts $1.83 -0.05 (-2.66%) (As of 12:07 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 1EstimatedActual EPS (Aug. 6) -$0.45 Beat By $0.37 Consensus EPS (Aug. 6) -$0.82 Conference Call TranscriptConference Call AudioEarnings Press Release Get Protara Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for TARA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTARA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TARA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move is being made in preparation to onboard all of Sony products (including Sony's Playstation, which captured a record 62% share of the global gaming console market in 2024). Enthusiasts and experts are buzzing with anticipation qnd one little-known crypto coin is poised for RAPID growth as we see this all unfold.Click here to review my research and unique strategy to score potential profits from this under-the- Protara Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.02)($1.02)($1.02)Q2 20241($1.09)($1.09)($1.09)Q3 20241($0.48)($0.48)($0.48)Q4 20241($0.51)($0.51)($0.51)FY 20244($3.10)($3.10)($3.10)TARA Earnings Date and InformationProtara Therapeutics last issued its quarterly earnings data on August 6th, 2024. The reported ($0.45) EPS for the quarter, beating analysts' consensus estimates of ($0.82) by $0.37. Protara Therapeutics has generated ($3.74) earnings per share over the last year (($3.74) diluted earnings per share). Earnings for Protara Therapeutics are expected to decrease in the coming year, from ($2.96) to ($2.99) per share. Protara Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off prior year's report dates.Read More Protara Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/1/2024(Estimated)------- 8/6/2024-($0.82)($0.45)+$0.37($0.45)-- 5/2/2024Q1 2024($0.99)($0.97)+$0.02($0.97)-- 3/13/2024Q4 2023($1.03)($0.90)+$0.13($0.90)-- 11/3/2023Q3 2023($1.10)($0.87)+$0.23($0.87)-- 8/3/2023Q2 2023($0.97)($1.00)($0.03)($1.00)-- 5/4/2023Q1 2023($1.00)($0.80)+$0.20($0.80)-- Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/8/2023Q4 2022($0.77)($0.84)($0.07)$1.78-- 11/3/2022Q3 2022($0.85)($0.68)+$0.17($0.68)--8/9/2022Q2 2022($1.13)($0.80)+$0.33($0.80)--5/5/2022Q1 2022($1.09)($0.96)+$0.13($0.96)--3/9/2022Q4 2021-($0.91)($0.91)($0.91)--11/4/2021Q3 2021($1.01)($0.96)+$0.05($0.96)--8/5/2021Q2 2021($1.00)($1.14)($0.14)($1.14)--5/6/2021Q1 2021($0.69)($1.20)($0.51)($1.20)-- 3/11/2021Q4 2020($0.36)($0.79)($0.43)($0.79)--11/12/2020Q3 2020($0.50)($1.26)($0.76)($1.26)--7/31/2020Q2 2020-($1.22)($1.22)($1.22)--5/13/2020Q1 2020($0.41)($1.81)($1.40)($1.81)--10/31/2019Q3 2019($3.60)($3.20)+$0.40($3.20)-- Protara Therapeutics Earnings - Frequently Asked Questions When is Protara Therapeutics's earnings date? Protara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off last year's report dates. Learn more on TARA's earnings history. Did Protara Therapeutics beat their earnings estimates last quarter? In the previous quarter, Protara Therapeutics (NASDAQ:TARA) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.82) by $0.37. Learn more on analysts' earnings estimate vs. TARA's actual earnings. How can I listen to Protara Therapeutics's earnings conference call? The conference call for Protara Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Protara Therapeutics's conference call transcript? The conference call transcript for Protara Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Protara Therapeutics generate each year? Protara Therapeutics (NASDAQ:TARA) has a recorded net income of -$40.42 million. TARA has generated -$3.74 earnings per share over the last four quarters. What is Protara Therapeutics's EPS forecast for next year? Protara Therapeutics's earnings are expected to decrease from ($2.96) per share to ($2.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BCLI Earnings Results CSBR Earnings Results TELO Earnings Results BIVI Earnings Results PRQR Earnings Results AMLX Earnings Results ME Earnings Results GBIO Earnings Results LFCR Earnings Results MCRB Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:TARA) was last updated on 9/16/2024 by MarketBeat.com Staff From Our Partners44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.